YOLFTbeta
Evogene

Evogene

EVGN · NASDAQ · Healthcare / Biotechnology

0.37USD+0.01 (+2.49%)

Price History

Full chart

Market Stats

Previous Close0.361
Open0.37
Day Range0.35 – 0.39
52-Week Range0.37 – 1.50
Volume62.60K
Market Cap6.70M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.63
Dividend Yield0.00%
Beta0.70
50-Day Avg0.5484
200-Day Avg0.7551

About

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD); and with ELEO, Inc. to develop oral small-molecule inhibitors targeting the PCSK9 pathway for the treatment of hyperlipidemia and cardiovascular diseases. The company was incorporated in 1999 and is headquartered in Rehovot, Israel.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Ofer Haviv CPA
  • Employees38
  • Headquarters13 Gad Feinstein Street, Rehovot, Israel, 7638517, USA
  • Websitehttps://www.evogene.com

Leadership

  • Mr. Ofer Haviv CPACEO, President & Director · b. 1966
  • Mr. Yoash ZoharChief Executive Officer of Casterra Ag Ltd. · b. 1967
  • Dr. Dan Jacob Gelvan Ph.D.Chief Executive Officer of Ag Plenus Ltd. · b. 1964
  • Ms. Polina RavzinChief Financial Officer · b. 1982
  • Dr. Ilia ZhidkovChief Technology Officer · b. 1977
  • Ms. Liat Foigel WejgmanVice President of Human Resources
  • Dr. Gabi Tarcic Ph.D.Chief Development Officer · b. 1980

Financials

Income Statement

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue14.90M17.07M17.58M14.51M11.13M6.54M3.38M1.75M753.00K1.04M930.00K1.68M2.98M5.58M3.85M
Growth (%)-+14.57%+2.98%-17.46%-23.31%-41.23%-48.30%-48.33%-56.90%+38.11%-10.58%+80.11%+78.03%+87.02%-30.91%
Cost of Revenue8.25M9.55M10.11M9.71M8.26M5.64M2.85M1.45M334.00K574.00K767.00K909.00K1.49M2.38M4.09M
Gross Profit6.65M7.52M7.47M4.80M2.87M901.00K536.00K295.00K419.00K466.00K163.00K766.00K1.49M3.20M-241.00K
Gross Margin44.65%44.05%42.47%33.09%25.82%13.78%15.85%16.89%55.64%44.81%17.53%45.73%50.03%57.32%-6.25%
Operating Expense9.84M10.65M16.19M20.06M20.80M21.99M22.48M20.28M21.59M25.28M31.12M27.71M23.72M22.00M13.79M
Operating Income-3.18M-3.13M-8.72M-15.26M-17.92M-21.09M-21.95M-19.99M-21.17M-24.81M-30.95M-26.94M-22.23M-18.80M-14.03M
Operating Margin-21.36%-18.31%-49.60%-105.13%-161.03%-322.46%-649.13%-1144.19%-2810.89%-2385.96%-3328.28%-1608.42%-745.51%-337.17%-364.24%
EBITDA-1.76M-1.29M-6.68M-13.01M-15.49M-18.81M-18.68M-18.76M-16.02M-23.21M-27.88M-27.01M-20.53M-13.36M-12.20M
EBITDA Margin-11.84%-7.56%-37.99%-89.64%-139.17%-287.61%-552.56%-1073.96%-2127.49%-2231.73%-2998.17%-1612.48%-688.53%-239.63%-316.56%
Net Income645.00K-2.52M-8.88M-14.53M-17.21M-19.59M-20.84M-20.76M-18.11M-23.37M-27.79M-26.64M-23.88M-16.48M-8.48M
Net Income Margin4.33%-14.77%-50.50%-100.13%-154.67%-299.57%-616.33%-1188.21%-2405.31%-2247.50%-2988.49%-1590.33%-800.77%-295.59%-220.22%
R&D6.38M7.25M11.11M14.02M14.45M16.41M16.99M14.69M15.79M17.29M21.13M20.79M16.20M12.51M7.99M
R&D as % of Total Revenue42.84%42.48%63.18%96.63%129.83%250.84%502.43%840.64%2097.08%1662.21%2271.51%1241.31%543.13%224.33%207.47%
Interest Expense7.00K89.00K87.00K200.00K195.00K155.00K129.00K141.00K354.00K269.00K403.00K241.00K171.00K124.00K1.89M
Interest Expense % of Total Revenue0.05%0.52%0.49%1.38%1.75%2.37%3.82%8.07%47.01%25.87%43.33%14.39%5.73%2.22%49.08%

Balance Sheet

Currency: USD2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets67.89M67.89M64.86M137.31M127.59M112.59M95.99M77.60M58.69M71.36M71.92M76.30M56.13M51.10M39.86M20.05M
Total Liabilities-19.80M16.60M12.56M11.50M8.84M8.70M8.22M8.39M11.15M15.03M12.88M21.34M22.42M25.03M8.07M
Total Equity-48.09M48.26M124.75M116.08M103.75M87.29M69.38M50.05M50.14M46.05M53.65M27.93M12.05M-1.45M-82.00K
Cash-6.46M24.26M95.45M5.21M10.22M3.24M3.44M5.81M34.75M46.23M32.33M28.98M20.77M15.30M12.96M
Total Debt---------2.97M2.44M2.67M11.93M11.51M12.87M2.20M
Net Debt---24.26M-95.45M-5.21M-10.22M-3.24M-3.44M-5.81M-31.78M-43.79M-29.66M-17.05M-9.27M-2.43M-10.76M

Cash Flow

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.13M-1.89M-5.27M-8.89M-12.41M-11.69M-15.93M-15.16M-17.36M-19.51M-24.84M-23.68M-21.58M-19.70M-13.50M
Investing Cash Flow-30.58M18.48M-2.90M-84.03M17.39M4.03M15.24M17.35M37.14M9.41M-20.44M13.27M-4.54M9.62M17.74M
Financing Cash Flow25.58M1.11M79.41M2.67M45.00K655.00K814.00K297.00K9.00M20.37M30.28M9.34M18.15M4.66M-6.60M
Capital Expenditure3.76M2.96M1.61M3.56M2.00M808.00K590.00K374.00K900.00K682.00K724.00K1.17M785.00K626.00K135.00K
Free Cash Flow-1.63M-4.85M-6.88M-12.46M-14.41M-12.50M-16.52M-15.54M-18.26M-20.20M-25.56M-24.85M-22.36M-20.33M-13.64M
FCF to OCF-76.23%256.94%130.61%140.07%116.16%106.91%103.70%102.47%105.18%103.49%102.91%104.95%103.64%103.18%101.00%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Aug 28, 2013Nov 27, 2013Mar 19, 2014May 7, 2014Aug 20, 2014Nov 10, 2014Feb 26, 2015May 19, 2015Aug 5, 2015Nov 18, 2015Mar 1, 2016May 19, 2016Aug 11, 2016Nov 21, 2016Feb 27, 2017May 17, 2017Aug 10, 2017Nov 22, 2017Feb 28, 2018May 29, 2018Aug 8, 2018Nov 14, 2018Mar 13, 2019May 7, 2019Jul 31, 2019Nov 23, 2019Mar 4, 2020May 26, 2020Aug 5, 2020Nov 18, 2020Mar 3, 2021May 26, 2021Aug 11, 2021Nov 17, 2021Mar 10, 2022May 26, 2022Aug 31, 2022Nov 17, 2022Mar 9, 2023May 18, 2023Aug 17, 2023Nov 15, 2023Mar 7, 2024May 23, 2024Aug 22, 2024Nov 21, 2024Mar 5, 2025May 21, 2025Aug 19, 2025Nov 20, 2025Mar 5, 2026May 20, 2026Aug 18, 2026Nov 19, 2026
EPS Estimate------------------------0.08-1.19-1.20-1.19-1.28-1.87-1.88-1.53-1.40-1.10-1.10-0.70-1.80-1.80-1.40-1.70-2.10-0.19-0.19-0.18-0.190.300.190.180.34---1.70-1.70-1.80-1.65-1.77-2.00-1.80-1.90-1.97-0.20-1.60-1.75-1.57-1.40-0.90-1.20-1.01-0.72-0.50-0.63-0.41-0.41-0.27-0.27-0.27
EPS Actual-1.14-1.20-7.291.24-1.20-2.801.40-0.29-2.802.20-2.40-2.010.671.53-1.28-0.500.25-0.65-0.55-0.41-0.26-1.00-1.18-0.20-0.90-1.30-1.70-1.90-1.30-2.00-1.30-2.20-1.30-1.80-2.00-2.60-1.90-1.80-2.00-2.40-2.10-1.90-1.90-0.23-0.15-0.16-0.16-0.24-0.24-0.16-0.17-2.50-1.70-1.50-1.90-1.80-2.00-2.10-1.60-0.07-1.50-1.70-0.80-1.30-0.80-1.06-1.310.06-0.38-0.50-0.46-0.62-0.61-0.13-
Surprise------------------------150.00%24.37%-8.33%-42.86%-48.44%30.48%-6.38%15.03%-57.14%-18.18%-63.64%-185.71%-44.44%-5.56%-28.57%-17.65%-14.29%-1005.26%-900.00%-955.56%-21.05%-150.00%-184.21%-188.89%-170.59%--90.00%-47.06%5.56%9.09%-7.34%10.00%-11.11%-10.53%18.78%65.00%6.25%2.86%49.04%7.14%11.11%11.67%-29.70%108.28%24.00%20.63%-12.20%-50.59%-125.93%51.85%-
Timing------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market---After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap6.70M
Enterprise Value379.74K
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales4.04
Price / Book4.71
EPS-1.63
Book Value-0.243
Revenue (TTM)1.66M
Gross Profit (TTM)-1.12M
EBITDA-13.97M
Profit Margin0.00%
Operating Margin-738.62%
Return on Equity-182.75%
Return on Assets-37.80%
Shares Outstanding15.80M
Shares Float12.38M
Beta0.70
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 2.15
  • Strong Buy
    2

Ownership Breakdown

Institutions
6.36%
Insiders
27.86%
Retail / Other
65.78%

Top Institutional Holders

  • Armistice Capital, LLC
    456.59K2.89%
  • Citadel Advisors Llc
    50.53K0.32%
  • Jane Street Group LLC
    18.50K0.12%
  • XTX Topco Ltd
    12.72K0.08%
  • TWO SIGMA SECURITIES, LLC
    12.46K0.08%
  • Daytona Street Capital LLC
    9.25K0.06%
  • BNP Paribas Arbitrage, SA
    9.12K0.06%
  • UBS Group AG
    6.35K0.04%
  • Morgan Stanley - Brokerage Accounts
    3.85K0.02%
  • Steward Partners Investment Advisory, LLC
    5050.00%
  • Federation des caisses Desjardins du Quebec
    5000.00%
  • Advisor Group Holdings, Inc.
    1000.00%
  • SBI Securities Co Ltd
    720.00%
  • SHP Wealth Management
    650.00%
  • Royal Bank of Canada
    420.00%
  • Acadian Asset Management LLC
    00.00%
  • Tradewinds Capital Management, LLC
    00.00%
  • Altshuler Shaham Ltd
    00.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • P & S Renditefonds T
    10.00K0.06%

Stock Splits

  • Jul 25, 20241:10